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Summary 
MHC class I genes are potently repressed by HIV Tat, 
which transactivatea the HIV LTR. Tat represses class 
I transcription by blnding to complexes associated 
with a novel promoter element, consisting of Spl-like 
DNA binding sites. Transcription by other Spl-depen- 
dent promoters, such as MDRl and the minimal SV40 
promoters, is also repressed by Tat, whereas the hu- 
man p-actin promoter is neither activated by Spl nor 
repressed by Tat. Tat repression can be overcome by 
a strong enhancer element. Thus, the SV40 72 bp en- 
hancer element confers protection from Tat-mediated 
repression on both the minimal SV40 promoter and 
the class I promoter. Surprisingly, Tat can activate the 
class I promoter In the presence of both the HIV TAR 
element and a strong upstream enhancer. These data 
demonstrate that Tat differentially affects Spl -reapon- 
sive promoters, depending on promoter architecture. 
Introduction 
HIV-1 infection of cells triggers de novo synthesis of viral 
gene products and causes altered expression of cellular 
genes. Such altered cellular gene expression in infected 
cells has been associated with the onset of immunodeficie- 
ncy (Cullen, 1991 a; Haseltine, 1991; Vaishnav and Wong- 
Staal, 1991), central nervous system pathology (Taylor et 
al., 1992; Cupp et al., 1993), formation of neoplasias (En- 
soli et al., 1992,1994; Barillari et al., 1993) and avoidance 
of immune surveillance (Howcroft et al., 1993). In addition 
to the structural genes gag, PO/, and env, HIV-1 encodes 
at least six regulatory proteins. At least four of these regu- 
latory proteins, Tat, Nef, Vpu, and Vpr, have been shown 
to affect cellular gene expression, although their mecha- 
nisms of action vary. Whereas Nef and Vpu reduce cell 
surface expression of CD4 by posttranslational mecha- 
nisms (Benson et al., 1993; Aiken et al., 1994; Willey et 
al., 1992) Vpr and Tat have been demonstrated to alter 
the transcription of avariety of cellular genes in vitro (Levy 
et al., 1993; Howcroft et al., 1993). 
HIV-1 Tat has been characterized as a potent activator of 
viral genome transcription and appears to function through 
two independent mechanisms. The 5’end of the viral RNA 
contains a stem-loop structure, the TAR element, which 
binds Tat. Tat interaction with the viral TAR sequence is 
thought to stabilize transcription complexes, resulting in 
an increased rate of transcription (Marciniak et al., 1990), 
and also to promote efficient elongation of the viral tran- 
script (Kato et al., 1992; Cullen, 1993). Tat also directly 
activates transcription through interactions with the initia- 
tion complex (Berkout et al., 1990). The effects of Tat on 
cellular genes are less well characterized. 
Recently, we reported that Tat represses transcription 
of major histocompatibility complex (MHC) class I genes 
(Howcroft et al., 1993) whose products play a pivotal role 
in the initiation and propagation of immune responses by 
serving as receptors for viral peptides and as targets for 
specific cytotoxic T lymphocytes (CTLs) (Koup, 1994; Hill 
and Ploegh, 1995; Townsend and Bodmer, 1989). Tat pro- 
tein is expressed in two alternative forms, only one of 
which iseffective in repressing MHCclass I gene transcrip- 
tion. Early during infection, prior to the appearance of Rev, 
Tat protein derives from a fully spliced viral transcript, and 
is encoded by two structural exons (Vaishnav and Wong- 
Staal, 1991; Cullen, 1991 b). This two exon-derived Tat 
protein varies in length between 88-101 aa, depending 
on the viral isolate. Following the onset of Rev activity, 
unspliced viral transcripts give rise to a Tat protein of 72 
aa, derived from only the first structural exon. Whereas 
both forms of Tat efficiently activate the viral long terminal 
repeat (LTR), only the completely spliced two-exon form 
of Tat represses MHC class I transcription (Howcroft et 
al., 1993). Recent studies suggest that the ability of Tat 
to repress MHC class I transcription is independent of 
its activation of the LTR, and that these activities map to 
distinct protein domains (J. B., T. K. H., and D. S. S., 
unpublished data). Tat-mediated reduction in transcription 
correlates with reduced cell surface expression of class 
I. These findings raise the intriguing possibility that during 
HIV infection, reduced MHC class I levels allow virus to 
remain hidden from immune surveillance. 
In addition to MHC class I, a variety of cellular genes 
have been reported to be modulated by Tat in infected 
cells. Among these genes are those clearly involved in 
immune responses, such as tumor necrosis factor (TNF) 
(Sastry et al., 1990) and TNF receptor (Pocsik et al., 1992) 
interleukin-2 (IL-2) and IL-2 receptor (Purvis et al., 1992), 
IL-10 (Masood et al., 1994), and IL-8 (Scala et al., 1994) 
genes. Furthermore, a number of non-HIV-l viral genes 
have also been shown to be affected by Tat. Examples 
of these are the JC virus late promoter (Chowdhury et al., 
1993; Tada et al., 1990) the immediate-early promoter of 
CMV (Ho et al., 1991), and the HIV-2 LTR (Feng and Hol- 
land, 1988). It is important to note that the majority of pro- 
moters, both viral and cellular, are not affected by Tat. 
The molecular mechanisms by which Tat affects gene ex- 
pression are not known. Also unknown are the factors that 
determine which genes will be affected, and whether they 
will be activated or repressed by Tat. 
The ability of Tat to modulate cellular gene expression 
potentially contributes to viral persistence, despite avigor- 
ous host anti-HIV response. Thus, it is necessary to under- 
stand the molecular bases underlying the novel disparate 
effects of Tat on different promoters. In the present study, 
we have analyzed Tat-mediated repression of cellular pro- 
moters and report that two-exon Tat represses heterolo- 
gous promoters by acting directly on basal promoter se- 
quences. In particular, we have found that the MHC class 
I gene contains a novel promoter element consisting solely 
of an Spl-like DNA binding site. The trans-acting factors 
that bind this Spl-like element may be the target for Tat 
action. Further, upstream enhancer elements regulate the 
extent of the effect of Tat on the target promoter, and 
determine whether a promoter is susceptible to Tat-medi- 
ated repression. These data provide mechanisms for Tat 
activity and for its differential effects on different promot- 
ers, resulting in either activation or repression, and further 
suggest that Tat can diminish the anti-HIV immune re- 
sponse through repression of MHC class I expression. 
Results 
Dlfferentlal Effects of Tat Are Promoter Specific 
The effect of HIV Tat on different promoters was deter- 
mined following cotransfection of HeLa cells with an HIV 
proviral construct that expresses only two-exon Tat and 
one of three promoter constructs (Figure 1A). As has been 
previously described, HIV Tat is a potent activator of tran- 
scription from the viral HIV LTR promoter, increasing its 
activity by approximately 1 OO-fold. In marked contrast, HIV 
Tat was a potent repressor of MHC class I promoter activ- 
ity, reducing its activity by approximately lo-fold. Tat had 
only a minor enhancing effect on the extended viral SV40 
early promoter. The finding that HIV Tat has differing ef- 
fectson these three promoters raised the question of what 
factors determine these distinct responses. 
One possibility was that the effect of HIV Tat on the 
activity of a given promoter is determined by cell type; 
introduction of the same promoter into different cell types 
might result in different responses to Tat. To test this, the 
effect of HIV Tat on MHC class I promoter activity was 
examined in four different human cell lines: HeLa fibro- 
blasts, Jurkat T cell line, HMY B cell line, and the U937 
monocyte line. In each case, HIV Tat significantly reduced 
expression from the class I promoter, although the magni- 
tude of the repression varied between 2.5 to lO-fold (Fig- 
ure 1B). Since HIV Tat protein is known to activate the 
viral HIV LTR in each of these cell lines, cell type does 
not appear to determine the pattern of Tat activity. Rather, 
it appears that the differential effects of Tat protein are 
determined by inherent differences in the promoters them- 
selves. 
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Figure 1. Differential Effects of Tat Are Promoter Dependent 
(A) HeLacell fibroblastswere cotransfected with 1 ug HIV-1 pBennCAT 
(LTR), 5 ug class I (-313CAT) or 1 pg pSV&CAT (SV40) promoter 
constructs and 10 pg either control or Tat-expressing proviral con- 
structs. Bee Experimental Procedures for transfection protocols. Rep 
resentative of multiple experiments, the data are expressed as relative 
CAT activity normalized to control. 
(B) Human T cell (Jurkat), B cell (HMY), monocyte (U937). and fibro- 
blast (HeLa) cell lines were cotransfected with 5 sg of either -313CAT 
(HeLa) or -313LUC (Jurkat, HMY, U937) and 10 ug of either control 
(pNL-AO) or Tat-expressing (pNLdA) proviral constructs. HeLa trans- 
fections were by calcium-phosphate precipitation, whereas Jurkat, 
HMY, and U937 cells transfections were by electroporation. Average 
of two experiments, data are expressed as relative promoter activity 
normalized to control; the level of repression was similar in both experi- 
ments. 
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HIV Tat Regulation of Transcription Maps to the 
Minimal Promoter of MHC Class I and Requires 
an Spl-Like Binding Site 
To delineate the promoter requirements for Tat-mediated 
repression, we analyzed derivativesof the class I promoter 
construct for susceptibility to Tat-mediated regulation. The 
experiments shown in Figure 1 were done with a class 
I promoter construct that extended 313 bp upstream of 
transcription initiation. In addition to core promoter se- 
quences, this region contains a number of regulatory ele- 
ments, including the enhancer A sequence and the inter- 
feron response element (Figure 2A). Truncation of -313CAT 
to yield -50CAT removes these regulatory elements (Fig- 
ure 2A), leaving a minimal promoter whose basal activity, 
surprisingly, is only 2- to Sfold lower than -313CAT (data 
not shown). To determine whether sequences between 
-50 and -313 bp are necessary for Tat-mediated repres- 
sion, we assessed the effect of Tat protein on the minimal 
promoter construct -5OCAT. As shown in Figure 2A, both 
the full-length -313CAT construct and the minimal pro- 
moter construct, -5OCAT, are equally susceptible to repres- 
sion by HIV Tat. Thus, the target of Tat-mediated repres- 
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sion of transcription resides within 50 bp of transcription 
initiation in the class I promoter. 
Inspection of this 50 bp DNA sequence reveals the pres- 
ence of a variant TATA box, a sequence homologous to an 
initiator element (Inr), and a repeated CCACCC sequence 
homologous to an Spl binding site (S box) (Figures 28 and 
3). To determine which of these elements, if any, mediates 
Tat-induced repression, a series of mutant promoter con- 
structs was generated; each was tested both for its basal 
activity and for its response to Tat protein. Surprisingly, 
mutation of either the Inr alone (mutant Ml) or both the 
Inr and TATA box together (mutant M5) only minimally 
reduced basal promoter activity (see Figure 28). Mutation 
of only the TATA box region also had only a moderate 
effect (data not shown). In these mutants, transcription 
still originates within the class I initiator, as determined 
by primer extension (T. K. H. et al, unpublished data). 
Further, HIV Tat reduced the activity of these mutant pro- 
moter constructs to approximately the same extent as it 
reduced the wild-type promoter (see Figure 28). Thus, sur- 
prisingly, neither the TATA box nor the Inr appear to be 
required for basal promoter activity and neither serves as 
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Figure 2. Tat-Mediated Repression of Class I 
Maps to Minimal Promoter Sequences 
(A) HeLa cells were cotransfected with 5 ug 
of the class I reporter constructs, -313CAT or 
-5OCAT, and 10 pg of either control or Tat- 
expressing proviral constructs. Data are ex- 
pressed as relative promoter activity normal- 
ized to control. Regulatory motifs are illustrated 
at left (closed triangle, minimal promoter). 
(6) Class I promoter mutants were generated 
(see Experimental Procedures) and tested for 
their ability to be repressed by Tat. Left, ele- 
ments remaining intact in each construct 
(hatched bar, TATA box; closed ovals, CCA- 
CCC; stippled bar, lnr). Right, the activity of 
each construct. HeLa fibroblasts were cotrans- 
fected with 5 ug of each mutant and 10 pg 
either control or Tat-expressing proviral wn- 
struct. Data are expressed as percent acety- 
lation. 
Figure 3. Sequence of Class I Promoter Re. 
gion Mutants 
Wild Type: 
,nr M, 
I”, M6 
I”, MrJ 
+1 
CGGCGCCACTGCGGrrCCCGGTTCTIIICTAAACTCTCCACCCACCCGGCTCTGCTCAG~CTCCCCAG 
------------------------------c-c~c---- 
------------------- ----------- 
-------- ______ ~------ACcc----GGCIGGACGA---. 
Underline shows mutated bases; shadow 
shows deleted bases. 
the target of Tat-mediated repression. Remarkably, a mu- 
tant promoter construct in which both the S boxes have 
been mutated (leaving the TATA box and Inr intact and 
maintaining their spacing) is completely inactive in basal 
transcription (see Figure 28; M6). Furthermore, introduc- 
tion of the M6 S box mutation into a class I promoter con- 
struct containing 416 bp of upstream sequence, -416CAT, 
also abolishes its promoter activity. These data thus iden- 
tify a novel type of promoter that does not depend on either 
a TATA box or Inr element, but rather depends on an Spl-like 
binding site, which is both necessary and sufficient for 
transcription initiation. (A detailed characterization of this 
promoter will be presented elsewhere; T. K. H. et al., un- 
published data.) By inference, this element is also the tar- 
get for Tat-mediated repression. 
Two&on Tat Forms a Complex with MHC Class I 
Promoter Binding Factore 
Although the preceding studies localize the target of Tat 
action to the S box region within the minimal promoter, 
they do not establish whether Tat repression occurs as a 
result of a direct interaction of Tat with the promoter. To 
address the question of whether two-exon Tat physically 
interacts with the class I promoter, we analyzed the effects 
of Tat on the mobility of promoter-specific complexes in 
gel-shiftassays.ADNAfragmentspanning the native mini- 
mal promoter sequence -52 to +14 bp formed two major 
complexes with HeLa whole cell extracts (Figure 4, lane 
2). These complexes are specific as evidenced by the ob- 
servations that they are competed by self-, but not non- 
self-, oligonucleotides, and they do not depend on the 
presence of either TATAA or Inr sequences in the probe 
(data not shown). 
Addition of a purified GST fusion protein containing two- 
exon Tat (GST-Tat 66) induced the formation of a novel 
slowly migrating complex (Figures 4A and 4B, see arrow). 
This induced complex was not generated by the addition 
of either purified GST fusion protein containing one-exon 
Tat (GST-Tat72), GST control protein, or purified cJun 
protein (Figure 4A). Addition of antibody to the GST epi- 
tope of the fusion protein resulted in a specific supershift 
of theGST-TatBGcontaining complex, but had noeffect in 
the presence of GST-Tat72 (Figure 48). Finally, antibody 
against the GST epitope had no effect on the mobility of 
bands seen with HeLaextract alone. Further evidence that 
Tat interacts with basal promoter complexes comes from 
the observation that in vitro transcribed and translated 
Tat66 also induces a novel slowly migrating complex with 
the class I promoter probe in the presence of HeLa extract 
(data not shown). These data demonstrate that factors that 
bind the basal promoter interact with Tat. Further, only 
two-exon Tat, which represses the class I promoter, is 
capable of interacting with these DNA binding factors; one- 
exon Tat, which does not repress, does not bind. These 
data thus also provide a structural correlate to the func- 
tional distinction between the two forms of Tat protein. 
Susceptibility to Tat Repression Correlates 
with Promoter Dependence on Spl 
Since the target site for Tat-mediated repression in the 
class I promoter maps to a region containing Spl -like bind- 
ing sites, Tat may function through interaction with an Spl 
family member. If true, this would predict a correlation 
between those promoters that are dependent on Spl (or 
Spl family members) for activity and those that are re- 
pressed by Tat. However, the SW0 early promoter, which 
was found to be refractory toTat-mediated repression (see 
Figure l), is known to contain six Spl binding sites (the 
21 bp repeats) and to be activated by Spl (Dynan and 
Tjian, 1966; Gidoni et al., 1964, 1965). Thus, the minimal 
SV40 promoter is either inherently resistant to repression 
by Tat, or the promoter is protected from repression by 
SV40 viral regulatory elements. To investigate this latter 
possibility, derivative SV40 promoter constructs were gen- 
erated. (Although the promoter activity of the constructs 
was reduced in proportion to the number of regulatory 
elements removed, all of the constructs retained readily 
measured levels of activity; assay conditions were ad- 
justed to be in the linear range of the CAT assay.) Removal 
of one of the two enhancer elements generated the con- 
struct, pSVeCAT (Figure 5A). pSVe,CAT, like pSVe&AT, 
was refractory to Tat-mediated repression (Figure 58). 
However, the construct pSVe&AT, which contained only 
the minimal SV40 promoter and the 21 bp Spl-binding 
site repeats was sensitive to Tat-mediated repression (Fig- 
ure 5). The magnitude of this repression was equivalent 
to that observed with the class I promoter, approximately 
lo-fold. These data demonstrate that the viral SV4Cl mini- 
mal promoter is inherently susceptible to Tat-mediated re- 
pression, but protected by the presence of the viral en- 
hancer elements. Thus, DNA sequences within the 72 bp 
enhancer repeat are able to modulate Tat protein repres- 
sion: a single copy of the enhancer is sufficient to abrogate 
Tat-mediated repression. 
A possible correlation between susceptibility to Tat- 
mediated repression and Spl dependence was then ex- 
amined for both the SV40 minimal promoter and the MHC 
class I promoter, as well as for the MDRl and human 
B-actin promoters. The MHC class I promoter, which was 
not known to be activated by Spl, was examined for its 
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Figure 4. Two-Exon Tat, but Not One-Exon Tat, Binds Directly toCorn- 
plexes Associated With the Class I Minimal Promoter 
(A) Gel-shift assays were performed with whole cell extracts prepared 
from HeLa a3 fibroblasts. Extracts were incubated with a YP-labeled 
oligonucleotide spanning the region -52 to +14 bp of the class I pro- 
moter (see Experimental Procedures), in the presence or absence of 
purified proteins GST-Tat66, GST-Tat72, GST-control. or cJun and 
electophoresed in a native polyacrylamide gel. HeLa whole cell ex- 
tracts generated two major complexes with the class I promoter probe. 
The arrow indicates the position of the slower migrating complex that 
results from the addition of increasing GST-Tat66 (0.3 ug, 0.6 ug, 1.2 
ug). No complexes with the probe were formed by the addition of 
Tat-66 alone, in the absence of HeLa extract. 
(8) GST-Tat66 induces a novel slowly migrating complex (see arrow), 
when added to HeLa whole cell extract, that is supershifted by the 
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Figure 5. The SV40 72 bp Enhancer Protects the Minimal Promoter 
from Tat-Mediated Repression 
(A) Map of SV40 promoter constructs: pSVe&AT contains the SV40 
promoter and both 72 bp enhancer elements; pSVe,CAT contains only 
one 72 bp repeat and was generated by removing the sequences 
between the two Sphl sites; and pSVe&AT is truncated just distal to 
the six Spl elements. 
(B) HeLa cells were cotransfected with 1 pg pSVe2CAT or pSVe,CAT, 
or 5 ug pSVe&AT and 10 pg of either control or Tat-expressing proviral 
constructs. Data are expressed as relative promoter activity normal- 
ized to control. 
response to Spl . Transfection into Drosophila SL2 cells 
(which contain no endogenous Spl activity) in the pres- 
ence of an Spl expression vector markedly activated the 
class I minimal promoter (Figure 6, left). The same pro- 
moter construct was markedly repressed by Tat, when 
cotransfected into HeLa cells (Figure 6, right). Similarly, 
the SV40 minimal promoter and the MDRl promoter were 
addition of anti&ST antibodies (0.3 ug). No GST-Tat72-induced com- 
plex was observed associated with the class I minimal promoter. No 
complexes with the probe were formed by antibody alone. 
Spl Activation Tat Repression 
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Figure 6. Tat-Mediated Repression Correlates with Spl Activation 
Promoter constructs used represent class I (-50 CAT), pSVe&AT 
(S&O), MDRI (multiple drug resistance), and human f3-actin (actin) 
genes. 
(Left) The ability to be activated by Spl was determined in Drosophila 
SLZ cells by cotransfection of 10 ug DNA of each promoter construct 
and 3 pg control or Spl expression vector DNA. Data are expressed 
as fold induction (Splkontrol). 
(Right) The ability of Tat to repress each promoter construct was deter- 
mined in parallel with Spl activation. HeLa cells were transfected with 
5 ug DNA of each reporter construct and 10 ug DNA of control or Tat 
expressing proviral constructs. Data are presented as relative pro- 
moter activity (Tat/control). 
both sensitive to Spl activation and Tat-mediated repres- 
sion (Figure 6). Conversely, the p-actin promoter was nei- 
ther activated by Spl, nor repressed by Tat (Figure 6). 
Taken together, these results are consistent with the inter- 
pretation that Tat protein mediates repression of a minimal 
promoter through Spl or an Spl family member and that 
the presence of an Spl-like binding site is necessary for 
a promoter to be susceptible to repression. Whether Spl 
itself, or a family member, activates the class I promoter 
in vivo remains to be determined. 
The presence of an Spl-like binding site in the promoter 
is not sufficient to confer susceptibility to Tat-mediated 
repression, since introduction of an Spl-binding site, 
namely the class I S box, into the 3-actin promoter did not 
alter its susceptibility. Thus, the relative effect of Tat on 
the p-actin promoter containing the class I S box sequence 
(1.1 f 0.17) was no different from its effect on the native 
3-actin promoter (1 .O f 0.09). 
Protection from Tat-Mediated Repression Requires 
the Entire Copy of the SV40 Viral Enhancer 
Although the SV40 minimal promoter is susceptible to Tat 
repression, a single copy of the enhancer protects the 
promoter from repression (see Figure 5). The 72 bp en- 
hancer element of the SV40 promoter is known to contain 
a number of binding sites for various transcription factors, 
including Ott-1, NF-KB, AP-1, AP-2, and AP-3. These sub 
elements act in concert to enhance normal viral promoter 
activity. Thus, the protection from Tat-mediated repres- 
sion by the viral enhancer could reflect the activity of a 
single subelement within the enhancer, or could be due 
to the combined effects of the multiple elements resident 
within the 72 bp unit. To distinguish between these possi- 
bilities, fragments of the 72 bp enhancer were cloned indi- 
vidually upstream of the minimal SV40 promoter; the indi- 
vidual subelements were approximately equally effective 
in activating basal promoter activity (data not shown). The 
ability of each of these subelements to protect from Tat- 
mediated repression was assessed (Figure 7). Whereas 
the entire 72 bp repeat confers complete protection from 
repression, none of the isolated subelements was capable 
of protecting the SV40 minimal promoter from Tat-mediated 
repression. Thus, all three of the promoter constructs con- 
taining individual enhancer subelements were repressed 
in the presence of HIV Tat. From this, we conclude that 
protection from Tat-mediated repression requires the com- 
bined effects of the enhancer subelements contained 
within the 72 bp repeat, suggesting that protection re- 
quires a strong enhancer. 
In contrast with the extended SV40 early promoter re- 
gion, the 313 bp class I promoter is sensitive to Tat repres- 
sion, although it contains a series of regulatory elements 
(see Figure 2A). The differential sensitivity of these two 
extended promoters to repression by Tat could reflect ei- 
ther differences in the ability of regulatory elements to 
protect, or differences in the ability of the minimal promot- 
ers to be protected. To assess these alternatives, the viral 
72 bp enhancer was introduced upstream of both a mini- 
mal class I promoter and the extended 313 bp class I pro- 
moter construct (Figure 8A). The effect of the presence 
of the viral enhancer element on Tat-mediated repression 
in the two class I promoter constructs was determined. In 
both cases, introduction of the viral enhancer rendered 
the class I promoter resistant to Tat-mediated repression 
(Figure 8B). Thus, protection from Tat repression is a prop 
erty of the viral enhancer, not of the promoter. Since sub- 
elements of the viral enhancer are ineffective, the ability 
of the 72 bp enhancer to protect may be a function of 
overall enhancer strength. 
Tat-mediated transactivation of the HIV LTR is en- 
hanced by the presence of the viral TAR element, an RNA 
sequence that binds Tat. To determine whether TAR se- 
quences can have any effect on the class I promoter, the 
TAR sequence was interposed between the class I pro- 
moter and the reporter gene, CAT, in the 313 bp promoter 
construct (Figure 8A); the TAR element did not affect basal 
promoter activity (data not shown). In the presence of Tat, 
the class I promoter containing the TAR element was still 
repressed (Figure 8C), although not to the same extent 
as the class I promoter alone (data not shown). In the 
presence of both the viral enhancer and the TAR element, 
the class I promoter was no longer repressed, but instead 
was activated by Tat, to a level of 2- to 5fold (Figure 8B). 
These data suggest that the activating or repressing po- 
tential of Tat is regulated by the combination of distinct 
sequence elements and host cellular factors. 
Discussion 
Many viruses, including HIV-l, encode proteins that regu- 
late the expression of both viral and host cellular genes. 
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(A) The 72 bp SV40 enhancer sequence was 
subdivided into three segments, which con- 
tained binding sites for NF-KB, including over- 
lapping AP-2 and AP-3 sites (+NF+BCAT), an 
octamer motif (+Oct-lCAT), or an AP-1 ele- 
ment (+AP-1CAT). Each individual subele- 
ment was cloned upstream of the Spl repeats 
in pSVe&AT. 
(6) HeLa cells were cotransfected with 5 pg 
DNA of the indicated SW0 subelement con- 
struct and 10 fig DNA of control or Tat- 
expressing proviral construct. Data are ex- 
pressed as relative promoter activity compared 
with pSVe,CAT, which was not repressed by 
Tat. 
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The HIV-1 protein Tat transactivates viral gene expression 
and is required for viral replication. HIV-1 Tat also re- 
presses the transcription of a some cellular genes, which 
could result in decreased efficacy of antiviral host re- 
sponses. Among such cellular genes whose transcription 
is reduced by HIV-1 Tat are the MHC class I genes (How- 
croft et al., 1993). We have proposed that such repression 
of class I gene transcription, and the attendant reduced 
cell surface expression of the class I molecules, would 
result in reduced viral antigen presentation and, conse- 
quently, a diminished effector phase of the immune re- 
sponse to HIV-1 infection. Thus, reduced cell surface ex- 
pression of class I in HIV-l-infected cells would permit the 
accumulation of a persistent reservoir of virus-producing 
cells refractory to class l-restricted CTL elimination. 
The present studies have defined the molecular mecha- 
nisms governing Tat-mediated effects on transcription. 
We have shown that the effect of HIV-1 Tat on transcription 
depends not only on the Tat protein itself, but also on the 
target promoter, since different promoters are activated, 
repressed, or not affected by Tat, independent of cell type. 
Those promoters that are repressed by Tat are dependent 
on Spl or Spl-like factors. Conversely, an Spl-indepen- 
dent promoter is not repressed by Tat. Further, Tat-mediated 
repression of susceptible promoters can be overcome by a 
strong upstream enhancer. Taken together, these results 
indicate that Tat represses the subset of Spl family-de- 
pendent promoters, and that the extent of the Tat effect 
is determined by the regulatory milieu and architecture of 
the target promoter. Thus, these studies begin to delineate 
a mechanism whereby HIV-l Tat simultaneously enhances 
viral infectivity while reducing host immune responsiveness. 
Cellular promoters have been classified as either TATAA 
dependent or Inr dependent (Smale and Baltimore, 1989; 
Javahery et al., 1994). The human P-actin and MDRl pro- 
moters are examples of classic TATAA and Inr promoters, 
respectively (van Groenigen et al., 1993; Ng et al., 1985). 
Indeed, all promoters described to date have been as- 
signed to one category or the other. In contrast, the MHC 
class I promoter sequence contains both a variant TATAA 
box and a consensus Inr, but neither is necessary for tran- 
scription. Rather, MHC class I transcription absolutely de- 
pendson the presence of two overlapping CCACCC motifs 
(S box), which are known DNA binding motifs for Spl or 
Spl-related transcriptionfactors(Chen etal., 1994; Baysal 
et al., 1994; Yu et al., 1991; Wang et al., 1993). As such, 
the MHC class I promoter appears to represent a novel 
type of promoter. (A detailed analysis of the promoter will 
be presented separately; T. K. H. et al., unpublished data.) 
Could differential susceptibility to Tat repression corre- 
late with the class of promoter? Susceptibility is unlikely 
to be determined solely by whether the promoter is TATAA- 
or Inr-driven, since the MHC class I promoter is susceptible 
to Tat repression, but does not critically depend on either 
TATAAor Inr elements for its basal activity. The SV40 early 
promoter and MDRl promoter are also Tat repressed, but 
have been described as TATAA- (Mack et al., 1993) and 
Inr-based (van Groenigen et al., 1993) promoters, respec- 
tively. These data suggest that the differential susceptibil- 
ity to Tat reflects an intrinsic difference among the promot- 
ers that is not directly related to the presence or absence 
of a TATAA box or Inr. 
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Figure 8. The SV40 Enhancer Protects the 
Class I Promoter from Tat-Mediated Repres- 
sion 
(A) The enhancer region of pSVeKAT (from 
the Hpall site to the Nwl site) including both 
72 bp repeats was subcloned into the Xbal site 
upstream of the class I promoter constructs 
-@CATand-313CATtogenerateenhdSCAT 
and enhdl3CAT. Subsequently, the HIV-1 
TAR sequence was inserted downstream of ini- 
tiation in -313CAT and enhdl3CAT to gener- 
ate -313(TAR)CAT and enhJ13(TAR)CAT 
(see Experimental Procedures for details). 
(B) The ability of the SW0 enhancer to confer 
protection on a heterologous promoter was 
tested. HeLa cells were cotransfected with 5 
Ng DNA of the indicated reporter construct and 
IO Mg DNA of control or Tat-expressing proviral 
construct. Data are expressed as the ratio of 
promoter activity in the presence of Tat com- 
pared with in the absence of Tat, for each of 
the four constructs. 
(C) The effect of the HIV TAR element on Tat-mediated repression in the presence or absence of the SV40 enhancer was examined. HeLa cells 
were cotransfected with 5 pg indicated reporter construct and 10 pg control or Tat-expressing proviral construct. Data are expressed as the ratio 
of the promoter activity in the presence of Tat and the absence of Tat 
B 
0 
SV40 enhancer - + - + 
-68CAT -3 13CAT 
Reporter Constructs 
Cellular promoters also can be categorized according 
to their dependence on the Spl family of transcription fac- 
tors. Recently, five zinc finger proteins related to Spl have 
been described, defining a family of related DNA binding 
factors (Wang et al., 1993; Kingsley and Winoto, 1992; 
Hagen et al., 1992). The functional roles of these Spl 
family members are not known. One, htp, regulates T cell 
receptor gene expression, binding to both a Vfl promoter 
and the Vu silencer (Wang et al., 1993). Another, Sp3, 
represses transcription by binding Spl sites and preclud- 
ing binding of Spl (Hagen et al., 1994). The functions of 
the other family members have not been defined. 
Both the SV40 early promoter (Dynan and Tjian, 1983; 
Gidoni et al., 1984,1985) and the MDRl promoter (Cohen 
et al., 1994; Cornwell and Smith, 1993) are known to be 
Spl dependent in vivo. In Drosophila SL2 cells, which do 
SV40 enhancer - + 
-3 13(TAR)CAT 
not contain Spl (Courey and Tjian, 1988), expression of 
these promoters depends on the introduction of exoge- 
nous Spl. In contrast, the human p-actin promoter, which 
is not known to be Spl dependent, was not activated by 
Spl in SL2 cells. In the present study, we demonstrated 
that an MHC class I promoter can be activated by Spl in 
Drosophila SL2 cells, providing evidence of the depen- 
dence of this promoter on the Spl family. 
Tat repression occurred only among those promoters 
sensitive to Spl or Spl-like factors. The MHC class I, the 
minimal SV40, and the MDRl promoters were all re- 
pressed by Tat, whereas the fi-actin promoter was not. 
Furthermore, analysis of the Tat target site for repression 
in the MHC class I promoter mapped it to a DNA sequence 
element that binds Spl and Spl-like factors. It remains 
to be determined whether Spl itself, or an Spl-family 
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member, participates in the transcriptional regulation of 
MHC class I genes and serves as a target for Tat-mediated 
repression. 
Tat appears to repress the MHC class I promoter di- 
rectly, as evidenced by the finding that two-exon Tat forms 
a novel slowly migrating complex with the class I promoter. 
Since Tat does not bind to DNA directly, it is likely that 
Tat associates with the Spl-like factors bound to the class 
I S box DNA. Although Tat is known to bind Spl (Jeang 
et al., 1993) it is unlikely that Tat is interacting with Spl 
itself in the S box complex, since in our gel-shift assay, 
we were unable to detect Tat binding to purified recombi- 
nant Spl protein-S box complexes under conditions 
where its association was observed with native S box com- 
plexes derived from HeLa extracts (data not shown). 
These data suggest that two-exon Tat, but not onwxon 
Tat, binds an Spl -related factor present in the class I pro- 
moter complex. The functional consequence of Tat bind- 
ing to the S box complex could be an active repression 
mediated by Tat, a passive interference with the assembly 
of transcription complexes, or a squelching of Spl-like 
factors. Since novel complexes were induced by the addi- 
tion of Tat, we favor the first two possibilities. Tat binding 
to Spl -like factors may bring it into proximity of the TATA- 
binding protein component of TFIID, to which Tat also 
binds (Kashanchi et al., 1994). This association may result 
in the direct repression of transcription. If Tat actively re- 
pressed transcription, it might be predicted that introduc- 
ing an S box would be sufficient to allow Tat to associate 
and repress through the S box complex. Although repres- 
sion was not observed with a construct in which the S box 
was introduced upstream of the human 8-actin promoter, 
it is possible that either the human @actin promoter is 
inherently resistant to Tat, or that positioning of Tat relative 
to the transcription complex is critical to its activity. 
Alternatively, Tat might repress transcription through a 
passive mechanism, such as disruption of the association 
of an Spl-like coactivator with the transcription complex. 
Spl itself is known to bind the TFIID complex through 
interactions with dTAFlll lO(Hoeyet al., 1993); thisinterac- 
tion is critical for Spl-dependent transcriptional activity 
(Gill et al., 1994). Spl is also reported to bind TATA-binding 
protein directly (Emili et al., 1994) and to interact with hu- 
man TAFll55 (Chiang and Roeder, 1995). Tat might inter- 
fere with the interaction between Spl (or an Spl-related 
factor) and TATA-binding protein or a critical TATA-binding 
protein-associated factor. Studies are currently in prog- 
ress to define further the mechanism of Tat repression. 
Susceptibility to Tat-mediated repression is not only de- 
termined by the intrinsic structure of the promoter itself, 
but by the context in which that promoter occurs. The SV40 
early promoter, containing only the 21 bp GC box repeats 
to which Spl binds (Dynan and Tjian, 1983; Gidoni et al., 
1984, 1985) is susceptible to Tat-mediated repression. 
However, in the presence of the viral 72 bp enhancer, Tat 
repression is inhibited. This enhancer is composed of at 
least five distinct regulatory elements: NF-rcB, octamer, 
AP-1, AP-2, and AP-3 (Jones et al., 1988; Coleman et al., 
1992). None of these alone is able to reverse Tat repres- 
sion. However, when combined to generate the 72 bp en- 
hancer, these elements are able to inhibit repression by 
Tat. These data suggest that Tat-mediated repression is 
modulated by the presence of upstream regulatory els 
ments; the net extent of Tat repression is determined by 
the susceptibility of the basal promoter and the additive 
effects of the various upstream regulatory elements. Down- 
stream elements, such as TAR, also modulate Tat activity. 
Flanking the class I promoter with the SV40 enhancer and 
the HIV TAR element converts its response to Tat from 
repression to activation. Furthermore, since the activity of 
these elements may vary among different tissues, it is 
further possible that the extent of Tat repression of a given 
cellular gene may also vary in different cell types. 
In conclusion, we have demonstrated that HIV-1 Tat re- 
presses gene transcription through direct interaction with 
complexes associated with the basal promoter; it is likely 
that these complexes contain Spl-like factors. Such re- 
pression is observed only in the absence of strong up 
stream enhancers. As we have shown previously, the abil- 
ity to repress is limited to the two-exon form of Tat. The 
present study further demonstrates that two-exon Tat, but 
not one-exon Tat, interacts with complexes associated 
with the class I promoter. The present data are consistent 
with a model in which two-exon Tat interacts with MHC 
class I promoters to reduce transcription and, conse- 
quently, the expression of cell surface class I molecules. 
HIV-l-infected cells would thus present less class I-asso- 
ciated HIV peptides, and be more resistant to CTL- 
mediated lysis. This would provide a mechanism for HIV 
to generate a pool of chronically infected cells, which are 
invisible to the immune system, but which could produce 
the large number of viral particles associated with HIV 
infections. 
Expsrlmsntal Procedums 
Cdl Lines snd Cultlvatlon 
Human HeLa fibroblaats and U937 monocytes were grown in Dulbac- 
co’s modified Eagles’s medium (DMEM) supplemented with 2 mM 
Lglutamine. HEPES (pH 7.2) gentamicin sulfate (10 ug/ml) and 10% 
fetat bovine serum (FBS); HMY (B cell) was grown in RPM1 1940 sup 
plemented with 10% FBS, 1 mM sodium pyruvate, 1 x nonessential 
amino acids (GIBCO). 2 mM L-glutamine, and gentamicin sulfate (10 
&ml). All three lines were maintained in a humidified incubator at 
37‘C, 7% CO,. Jurkat (Tcell) were grown in RPM1 1640 supplemented 
with 10% FBS, 2 mM Lglutamine, 3 x 10-‘2-ME, 100 U/ml penicillin, 
100 U/ml streptomycin, and gentamicin sulfate (10 pglml) and main- 
tained at 37OC, 5% CD*. Drosophila Schneider (SL2) cells were grown 
in M3 media supplemented with 10% FBS, 2 mM Lglutamine, and 
gentamicin sulfate (10 pglml) and kept at rmm temperature. 
PlasmIds and Clonlng Stmtegles 
The MHC class I promoter used in these studies derived from the swine 
class I gene, PD7 (Ehrlich et al., 1999). The -313CAT and -99CAT 
constructs were previously described (Howcrofl et at., 1993); -30CAT 
was generated by truncation of -313CAT at the Narl site. Some experi- 
ments used the construct -313LUC in which the class I promoter 
region between the Xbal and Hindlll sites was subcloned into the Nhel- 
Hindlll sitesof pGLP-basic(Promega) upstream of the luciferasegene. 
Class I wild-type (Inr) and mutant (Inr Ml-M5) promoter constructs 
were generated by inserting synthetic double-stranded oligonucleo- 
tides into the Hindlll site of pSV0. The sense strand sequences of the 
oligos synthesized are illustrated in Figure 3. 
The two-exon Tat provirat construct, pNL-AA, used in all of the 
transfections was generated by mutating rev and nef reading frames 
(fill-in of BamHl and Xhol sites, respectively) of pNL-Al (Strebel et al., 
1988); this construct generates only Tat-86 The control construct, 
pNL-AO, was generated by removal of all proviral sequences between 
the BssHll and Kpnl sites. The SV40 constructs pSVe2CAT and 
pSVe&AT are the same as pSV&AT and pSV&AT, respectively. 
pSVe,CAT was generated by removing the sequences between the 
two Sphl sites and religating. The SV40 enhancer subelement con- 
structs were generated by replacing SV40 sequences between the 
Ndel and Sphl sitesof pSVe,CATwith synthetic oligonucleotidescorre- 
sponding to 
NF-rcB,GGGTGTGGAAAGTCCCCAGGCTCCC; 
Ott-1 , CAGCAGGCAGAAGTATGCAAAGCATGC; 
AP-1, ATCTCAATTAGTCAGCAA. 
To generate the hybrid SV4O-class I promoter constructs the SV40 
enhancer and promoter region of pSVe&AT (from the Hpall to the 
Hindlll sites) was subcloned into Accl-Hindlll sites of pUC19; the se- 
quence from the Ncol site to the Hindlll sites (containing the 21 bp 
repeats and promoter region) was removed and replaced with a syn- 
thetic oligonucleotide: 
CATGGGGATCCTCTAGAGAATTCA 
CCCTAGGAGATCTCTTAAGTTCGA 
containing the following restriction sites Ncol, BarnHI, Xbal, EcoRI, 
and Hindlll. Subsequently, the Xbal fragment containing the SV40 72 
bp repeats was subcloned into the Xbal site upstream of -68CAT, 
-313CAT, and -313(TAR)CAT. The -313(TAR)CAT was constructed 
by placing the TAR element downsteam of initiation in the -313CAT 
construct by synthesizing the following double-stranded oligonucleo- 
tide and ligating it into the unique Hindlll site and sequencing to deter- 
mine direction and authenticity. 
(TAR).S-AGCTTGGTCTCTCTGGTTACACCAGATCTGAGCCTGffiAGCTCTCTGGCT~C 
ACCAGAGAGACCAATCTGGTCTAGACTCGGACCCTCGAGAGACCGAT?G 
TAGGGAACCCACTGCTTAAGCCTCAATAT3’ 
ATCCCTTGGGTGACGAATTCGGAGTTATATCGA 
Spl and control plasmids pPacSp1 and pPac0, respectively, were 
provided by Dr. R. Tjian and described in Courey and Tjian (1988). 
The human p-actin promoter plasmid pHf3Apr-I-Neo CB17 was pro- 
vided by Dr. L. Kedes and described in Espeseth et al., 1989; Gunning 
et al., 1987; Germino and Bastia, 1995. The mutiple drug resistance 
promoter MDRl plasmid, pYMCAT, was provided by Dr. M. Gottesman 
and described in Chin et al. (1992). The HIV-1 LTR construct, pBenn- 
CAT, was provided by Dr. A. Rabson. 
Transfectlons 
Transient transfections were performed using a total of 20 ug DNA; 
reporter and test plasmids were adjusted to 20 ug with pUC19 su- 
percoiled DNA, as needed. HeLa fibroblasts (1 x 107 or 3 x lo8 
SL2 cells were seeded in 100 mm tissue culture dishes 24 hr prior to 
transfection. HeLa and SL2 transfections utilized standard calcium 
phosphate precipitation as previously described (Howcroft et al., 
1993). HeLa cells were fed 24 hr after transfection and cells harvested 
after an additional 24 hr; SL2 cells were harvested after 48 hr, with 
no medium replacement. Transfection of Jurkat, HMY, and U937 cells 
were carried out by electroporation of 10’ cells in 200 ul complete 
media (Rellahan et al., 1994) with 10 mM HEPES (pH 7.2) in a Gene 
Pulser (Bit-Rad Laboratories, Richmond, California) at 0.23 kV for 
Jurkat, 0.25 kV for HMY, and 0.27 kV for U937, with a capacitance 
setting of 960 uF. Cells were harvested 18-24 hr after electroporation 
and postnuclear supernatants were assayed for luciferase activity us- 
ing a Monolight 2010 luminometer (Analytical Luminescence Labora- 
tory, San Diego, California). CAT activity was determined in HeLa and 
SL2 cell lysates normalized for protein content (Pierce, Micro BCA 
Protein Assay Reagent Kit). Some transient transfections were normal- 
ized to f&galactosidase (Howcroft et al., 1993) by cotransfecting an 
internal plasmid control, CMV+-gal. CAT assays normalized by pro- 
tein content produced data equivalent to those normalized to P-galac- 
tosidase. CATactivity wasanalyzed with an AMBlS4000 radioanalytic 
imaging detector. All CAT enzyme assays were measured in the linear 
range; control “Cchloramphenicol values ranged between 20%- 
80%. among the different experiments. 
Gel-Shift Moblllty Aeeeys 
HeLe whole cell extracts were prepared as previously described 
(We&man and Singer, 1991). For gel-shift mobility assays, 4.5 ug of 
HeLa whole cell extracts was added to 1.5 frnol end-labeled 68 bp 
probe, corresponding to the class I promoter region from -52 to +I4 
bp. Extract, probe, purified proteins, and specific antibodies werecom- 
bined and incubated at 30°C for 30 min. Binding buffer consisted of 
12 mM HEPES (pH 7.9), 10% glycerol, 5 mM MgCC, 60 mM KCI, 1 
mM DlT, 50 pg/ml bovine serum albumin, 0.5 mM EDTA, 0.05% NP 
40 and 3 ug poly (dG-dC). DNA-protein complexes were separated 
from unbound free probe by electrophoresis through a nondenaturing 
4% acrylamide gel in 0.5x Tris-borate-EDTA running buffer run at 
160 V for 90 min at rmm temperature. Purified GST-control, GST- 
Tat86 and GST-Tat72 proteins were prepared using a modification 
of a standard protocol (Smith and Johnson, 1989); purified c-Jun was 
purchased from Promega. 
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